Universidad de Extremadura-ko ikertzaileekin lankidetzan egindako argitalpenak (15)

2023

  1. Influence of variability in the cyclooxygenase pathway on cardiovascular outcomes of nephrosclerosis patients

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. Effectiveness of CPAP vs. Noninvasive Ventilation Based on Disease Severity in Obesity Hypoventilation Syndrome and Concomitant Severe Obstructive Sleep Apnea

    Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 228-236

  2. Polymorphisms in glucose homeostasis genes are associated with cardiovascular and renal parameters in patients with diabetic nephropathy

    Annals of medicine, Vol. 54, Núm. 1, pp. 3039-3051

  3. Risk factors associated with pulmonary hypertension in obesity hypoventilation syndrome

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, Vol. 18, Núm. 4, pp. 983-992

  4. Tag-SNPs in Phospholipase-Related Genes Modify the Susceptibility to Nephrosclerosis and its Associated Cardiovascular Risk

    Frontiers in Pharmacology, Vol. 13

2021

  1. A custom target next-generation sequencing 70-gene panel and replication study to identify genetic markers of diabetic kidney disease

    Genes, Vol. 12, Núm. 12

  2. Genetic variants in pge2 receptors modulate the risk of nephrosclerosis and clinical outcomes in these patients

    Journal of Personalized Medicine, Vol. 11, Núm. 8

  3. Genetics variants in the epoxygenase pathway of arachidonic metabolism are associated with eicosanoids levels and the risk of diabetic nephropathy

    Journal of Clinical Medicine, Vol. 10, Núm. 17

2020

  1. Cost-effectiveness of positive airway pressure modalities in obesity hypoventilation syndrome with severe obstructive sleep apnoea

    Thorax, Vol. 75, Núm. 6, pp. 459-467

  2. Echocardiographic changes with positive airway pressure therapy in obesity hypoventilation syndrome long-term pickwick randomized controlled clinical trial

    American Journal of Respiratory and Critical Care Medicine, Vol. 201, Núm. 5, pp. 586-597

  3. Eficacia y coste-efectividad del diagnóstico y decisión terapéutica de la apnea obstructiva del sueño en atención primaria: descripción de la metodología.

    Revista española de patología torácica, Vol. 32, Núm. 4, pp. 260-274

  4. Long-term Noninvasive Ventilation in Obesity Hypoventilation Syndrome Without Severe OSA: The Pickwick Randomized Controlled Trial

    Chest, Vol. 158, Núm. 3, pp. 1176-1186

2019

  1. Long-term clinical effectiveness of continuous positive airway pressure therapy versus non-invasive ventilation therapy in patients with obesity hypoventilation syndrome: a multicentre, open-label, randomised controlled trial

    The Lancet, Vol. 393, Núm. 10182, pp. 1721-1732

2018

  1. Primary care physicians can comprehensively manage patients with sleep apnea a noninferiority randomized controlled trial

    American Journal of Respiratory and Critical Care Medicine, Vol. 198, Núm. 5, pp. 648-656

2011

  1. Visual analogical well-being scale for sleep apnea patients: Validity and responsiveness

    Sleep and Breathing, Vol. 15, Núm. 3, pp. 549-559